FDAnews
www.fdanews.com/articles/174286-hibergene-diagnostics-awarded-ce-mark-for-meningococcus-test

HiberGene Diagnostics Awarded CE Mark for Meningococcus Test

December 1, 2015

Dublin, Ireland-based HiberGene Diagnostics has won CE marking for its HG Meningococcus test for Meningococcal disease, a severe form of bacterial meningitis.

While current testing methods of growing the bacteria in a culture medium can take several days, HG Meningococcus — featuring loop-mediated isothermal amplification — provides results in less than an hour, the company says.

The test can be performed using a sample of whole blood, cerebrospinal fluid or from a nasopharyngeal swab.

The test will be available through a number of national distributors. — Michael Cipriano